Thermo Fisher Scientific
In Brief This Week: GeneDx; Danaher; Thermo Fisher Scientific; Cardio Diagnostics; More
News items for the week of May 5, 2025.
Roche, Diasorin, Siemens Healthineers, Others Gain 510(k) Clearances in April
April's clearances included respiratory disease assays, a Gram-negative infection test, and assays to aid the diagnosis and monitoring of thyroid disease.
Thermo Fisher Scientific Lowers 2025 Adjusted EPS Guidance in Light of Tariffs, US Policy Changes
Premium
The new guidance reflects the impact from China-related tariffs as well as dampening US grant funding, partially offset by the firm's mitigation actions.
Vendors, kit makers, and service providers using dPCR are crafting diverse strategies to ramp up adoption of the technology.
Roche, Abbott, Hologic, Cepheid, Others Gain 510(k) Clearances in February
The US Food and Drug Administration last month granted clearances for a preeclampsia risk test, respiratory disease tests, and a digital pathology system, among others.
Jan 30, 2025